World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
129
Citations
117762
World Ranking
2519
National Ranking
1419

Antonio M. Gotto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Antonio M. Gotto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 890 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Antonio M. Gotto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Antonio M. Gotto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 129 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2012 - Robert J. and Claire Pasarow Foundation Medical Research Award
  • 2001 - Fellow of the American Academy of Arts and Sciences
  • 1991 - Member of the National Academy of Medicine (NAM)
  • 1988 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Antonio M. Gotto is affiliated with Cornell University in the United States. Their research predominantly centers around medicine, with a significant focus on surgery, endocrinology, diabetes and metabolism, cardiology and cardiovascular medicine, economics and econometrics, and molecular biology.

The scientist's main topics of work include lipoproteins and cardiovascular health, diabetes, cardiovascular risks, and lipoproteins, cholesterol and lipid metabolism, health systems, economic evaluations, quality of life, diabetes treatment and management, cancer, lipids, and metabolism, as well as lipid metabolism and disorders.

Frequently publishing in notable venues, Gotto's work appears often in the Journal of Clinical Lipidology, Arteriosclerosis Thrombosis and Vascular Biology, Atherosclerosis, Journal of Lipid Research, and Circulation.

Among their recent papers are:

  • Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis, 2024, The Lancet Diabetes & Endocrinology
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet
  • High-density lipoproteins, reverse cholesterol transport and atherogenesis, 2021, Nature Reviews Cardiology
  • Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia, 2020, JAMA Cardiology
  • Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials, 2020, Journal of clinical lipidology

Frequent co-authors collaborating with Gotto include:

  • Henry J. Pownall
  • Corina Rosales
  • Baiba K. Gillard
  • Maciej Banach
  • P. Barton Duell

Antonio M. Gotto has received multiple awards over the years, including the Robert J. and Claire Pasarow Foundation Medical Research Award in 2012, fellowship of the American Academy of Arts and Sciences in 2001, membership of the National Academy of Medicine (NAM) in 1991, and fellowship of the American Association for the Advancement of Science (AAAS) in 1988.

Best Publications

  • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

    Andrew S. Levey;Josef Coresh;Kline Bolton;Bruce Culleton

  • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

    Paul M Ridker;Eleanor Danielson;Jacques Genest;Antonio M. Gotto

  • Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS

    John R. Downs;Michael Clearfield;Stephen Weis;Edwin Whitney

  • Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

    Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest

  • Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

    John C. LaRosa;Scott M Grundy;David D. Waters;Charles Shear

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

    Shaul G. Massry;Jack W. Coburn;Glenn M. Chertow;Keith Hruska

  • Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

    Paul M. Ridker;Nader Rifai;Michael Clearfield;John R. Downs

  • HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

    Philip Barter;Antonio M. Gotto;John C. LaRosa;Jaman Maroni

  • Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study

    Shih Jen Hwang;Christie M. Ballantyne;A. Richey Sharrett;Louis C. Smith

  • Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

    J R Patsch;G Miesenböck;T Hopferwieser;V Mühlberger

  • Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

    G. H. Dahlen;J. R. Guyton;Mohammad Attar;J. A. Farmer

  • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

    Paul M Ridker;Eleanor Danielson;Francisco Ah Fonseca;Jacques Genest

  • K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

    Andrew S. Levey;Michael V. Rocco;Sharon Anderson;Sharon P. Andreoli

  • AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology

    Sidney C. Smith;Steven N. Blair;Robert O. Bonow;Lawrence M. Brass

  • The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

    J. J. Brugts;T. Yetgin;S. E. Hoeks;Antonio Gotto

  • AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

    Sidney C. Smith;Steven N. Blair;Robert O. Bonow;Lawrence M. Brass

  • Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis

    S. Matthijs Boekholdt;Benoit J. Arsenault;Samia Mora;Terje R. Pedersen

  • Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

    San Hwan Chen;Geetha Habib;Chao Yuh Yang;Zi Wei Gu

  • Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease

    J.C. LaRosa;S.M. Grundy;D.D. Waters

Frequent Co-Authors

Henry J. Pownall
Henry J. Pownall Houston Methodist
Richard L. Jackson
Richard L. Jackson University of Cincinnati Medical Center
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Wolfgang Patsch
Wolfgang Patsch Paracelsus Medical University
David P. Hajjar
David P. Hajjar Cornell University
Scott M. Grundy
Scott M. Grundy The University of Texas Southwestern Medical Center
Paul M. Ridker
Paul M. Ridker Brigham and Women's Hospital
Maciej Banach
Maciej Banach John Paul II Catholic University of Lublin
Lawrence Chan
Lawrence Chan Baylor College of Medicine
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare but unsure if a traditional medical degree is right for them, there are several alternative online degrees and career pathways to consider. The healthcare industry offers a variety of roles beyond that of a medical doctor, many of which can be pursued via flexible and affordable online programs.

Leadership roles in hospitals and clinics are often filled by those with advanced administrative credentials, such as the cheapest online mha programs. For nurses aspiring to the highest level of clinical practice, enrolling in one of the best online dnp programs can open doors to advanced career opportunities.

Pharmacy is another key sector, and pharmacy careers are now more accessible thanks to accredited online pharmacy school programs. For those interested in data-driven roles that support patient care and healthcare operations, an online health information management degree can provide the specialized skills needed for this fast-growing field.

Exploring these online degree pathways can help you find the right fit and pursue a rewarding healthcare career tailored to your interests and goals.

Best Scientists Citing Antonio M. Gotto

Trending Scientists